Treating children with chronic myeloid leukemia in the imatinib era: a therapeutic dilemma?
Thornley
Ian
I
Perentesis
John P
JP
Davies
Stella M
SM
Smith
Franklin O
FO
Champagne
Martin
M
Lipton
Jeffrey M
JM
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002648:Child; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate